Susquehanna Fundamental Investments, LLC Dr Reddys Laboratories LTD Transaction History

Susquehanna Fundamental Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$59.5 - $67.25 $385,679 - $435,914	-6,482 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$60.19 - $75.29 $455,517 - $569,794	-7,568 Reduced 53.86%	6,482 $422,000
Q2 2021 Aug 11, 2021	BUY	$62.12 - $74.2 $90,074 - $107,590	1,450 Added 11.51%	14,050 $1.03 Million
Q1 2021 May 17, 2021	SELL	$57.98 - $73.08 $731,185 - $921,611	-12,611 Reduced 50.02%	12,600 $774,000
Q4 2020 Feb 16, 2021	BUY	$62.61 - $71.29 $251,003 - $285,801	4,009 Added 18.91%	25,211 $1.8 Million
Q3 2020 Nov 16, 2020	BUY	$51.39 - $72.41 $1.09 Million - $1.54 Million	21,202 New	21,202 $1.48 Million

245

23.1M

12.7K

6.1K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.55B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.